Glucagon-like peptide 1 receptor agonist, exendin-4, reduces alcohol-associated fatty liver disease
Sundararajan Mahalingam, Ramesh Bellamkonda, Madan Kumar Arumugam, Sathish Kumar Perumal, Jessica Yoon, Carol A. Casey, Kusum K. Kharbanda, Karuna Rasineni
Topics & Concepts
Internal medicineEndocrinologyFatty liverSteatosisAdiponectinInsulin resistanceAdipose tissueAgonistNEFAInsulinTriglycerideGlucagonGlucagon-like peptide 1 receptorMedicineType 2 diabetesGlucose tolerance testDiabetes mellitusReceptorCholesterolDiseaseLiver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseDiabetes Treatment and Management